West Virginia 2023 Regular Session

West Virginia House Bill HB2075

Introduced
1/11/23  

Caption

To provide a means to classify when medications should be continued or stopped for patients

Impact

If enacted, this bill will significantly impact state laws regarding prescription management and the responsibilities of pharmacies. The requirement for regular updates would necessitate changes in protocols for pharmacists, including how they communicate changes in medication regimens to patients and their healthcare providers. This is expected to help prevent medication errors, reduce adverse drug events, and ensure that patients receive consistent and accurate information regarding their medications.

Summary

House Bill 2075 aims to amend the Code of West Virginia by introducing a provision that requires pharmacists to receive medication status updates whenever there are changes to a patient's prescriptions. The bill proposes that the Board of Pharmacy develop rules to facilitate this process, ensuring that all pharmacies in West Virginia maintain accurate records of patients' medications, thereby enhancing the safety and efficiency of pharmaceutical care. The intent of the bill is to improve communication between healthcare providers and pharmacists, which can ultimately lead to better patient outcomes.

Sentiment

The sentiment surrounding HB 2075 appears positive among healthcare professionals and patient advocacy groups, who view the requirement for medication status updates as a critical step in improving patient safety. Proponents argue that this legislation will empower pharmacists to play a more active role in the healthcare delivery system, fostering collaborations between pharmacists and other healthcare providers. However, some concerns have been raised regarding the practicality of implementing such a system, particularly if sufficient resources and funding are not allocated to support these changes.

Contention

While the overall sentiment is favorable, there are points of contention related to the potential burden this may place on pharmacies. Some pharmacy representatives worry about the additional workload and the implications for small, independent pharmacies that may struggle to adopt the new requirements without sufficient support. The bill's effectiveness will hinge on how well these regulations are implemented and whether the Board of Pharmacy can provide the necessary guidance and resources to ensure compliance across the state.

Companion Bills

No companion bills found.

Similar Bills

CA SB1365

Pharmacy technicians: supervision.

CA SB1286

Pharmacy technicians.

CA AB1589

Pharmacy: pharmacist supervision: technicians.

CA SB362

Chain community pharmacies: quotas.

WI AB173

Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

WI SB203

Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

CA SB1442

Community pharmacies: staffing.

CA SB617

Pharmacy technicians: supervision.